May 2026
The global cancer biological therapy market size is expected to increase from USD 124.44 billion in 2025 and is predicted to reach at USD 266.75 billion by 2035, with a solid CAGR of 7.99%.
April 2026
The cancer gene therapy market size was estimated at USD 4.14 billion in 2025 and is projected to hit around USD 22.32 billion by 2035 with a CAGR of 18.35%.
April 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.66 billion in 2025, with a CAGR of 9.70%.
February 2026
The cancer immunotherapy market size is calculated at USD 136.39 billion in 2025 and is projected to hit around USD 367.63 billion by 2035, at a CAGR of 10.42%.
October 2025
The global exosome-based cancer therapy CDMO market is growing as demand rises for scalable manufacturing and delivery solutions in exosome therapeutics.
July 2025
Explore the oncology combination therapy market, driven by rising cancer prevalence, improved treatment efficacy through drug combinations, and advancements in personalized medicine.
June 2026
The global physical therapy market size is estimated to hit around USD 52.53 billion by 2035, increasing from USD 26.04 billion in 2025, with a CAGR of 7.27%.
June 2026
The global photothermal therapy patches market size is anticipated at USD 275.29 million in 2025 and is predicted to hit around USD 560.86 million by 2035, growing at a CAGR of 7.38%.
June 2026
The global pancreatic cancer precision medicine market size is estimated to hit around USD 4,611.83 million 2035 increasing from USD 823.30 million in 2025, with a CAGR of 18.80%.
June 2026
The breast cancer diagnostics market size is valued at USD 20.14 billion in 2025 and is projected to hit around USD 43.62 billion by 2035 with a CAGR of 8.03%.
June 2026
The global gene therapy market size was exhibited at USD 11.07 billion in 2025 and is predicted to hit around USD 63.52 billion by 2035 with a solid CAGR of 19.09%.
June 2026
The global induced pluripotent stem cell (iPSC) therapy market is driven by rising chronic disease prevalence, personalized medicine demand, and advances in regenerative technology.
June 2026
The global cancer therapeutics and biotherapeutics market size was valued at USD 210.73 billion in 2025 and is expected to hit around USD 475.26 billion by 2035, growing at a CAGR of 8.47%.
June 2026
The US cell and gene therapy market size was evaluated at USD 4.09 billion in 2025 and is predicted to hit around USD 20.00 billion by 2035, growing at a CAGR of 17.21%.
June 2026
The global phage therapy market size is evaluated at USD 1.29 billion in 2025 and is predicted to hit around USD 1.92 billion by 2035, growing at a CAGR of 4.06%.
June 2026
The global engineered TCR (T-Cell Receptor) therapy market is growing as immunotherapies advance for cancer and infectious disease treatment.
June 2026
The global oncolytic virus-based gene therapy market is growing rapidly as viral vectors are engineered to selectively target and destroy cancer cells.
June 2026
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
June 2026
The global neoantigen cancer vaccine market size is evaluated at USD 475.68 million in 2025 and is predicted to hit around USD 2,023.79 million by 2035, growing at a CAGR of 15.58%.
June 2026
The global T-cell immunotherapy market size is estimated to hit around USD 29.45 billion by 2035 increasing from USD 8.43 billion in 2025, with a CAGR of 13.33%.
June 2026
The global bladder cancer therapeutics diagnostics market size was valued at USD 5.68 billion in 2025 and is expected to hit around USD 10.04 billion by 2035, growing at a CAGR of 5.86%.
June 2026
The global oncolytic virus therapy market size is evaluated at USD 3.71 billion in 2025 and is predicted to hit around USD 12.31 billion by 2035, growing at a CAGR of 12.74%.
June 2026
The US brachytherapy market size was evaluated at USD 345.22 million in 2025 and is predicted to hit around USD 699.86 million by 2035, growing at a CAGR of 7.32%.
June 2026
The global proton therapy market size surpassed USD 648.64 million in 2025 and is projected to surpass around USD 2,229.88 million by 2035 with a CAGR of 13.14%.
June 2026
The global estrogen replacement therapy market size was evaluated at USD 11.75 billion in 2025 and is predicted to hit around USD 20.49 billion by 2035, growing at a CAGR of 5.72%.
June 2026
The global skin cancer diagnostic market size is evaluated at USD 8.97 billion in 2025 and is predicted to hit around USD 14.60 billion by 2035, with a CAGR of 4.99%.
June 2026
The global AAV gene therapy market size was evaluated at USD 2.85 billion in 2025 and is predicted to hit around USD 27.41 billion by 2035, with a CAGR of 25.39%.
June 2026
The US CAR T-cell therapy market size was evaluated at USD 2,299.97 million in 2025 and is predicted to hit around USD 11,510.04 million by 2035, growing at a CAGR of 17.47%.
June 2026
The solid tumor cancer treatment market size was valued at USD 5.64 billion in 2025 and is projected to hit around USD 9.14 billion by 2035 with a CAGR of 4.95%.
June 2026
The global salt therapy market size is projected to surpass around USD 20.57 billion by 2035 increasing from USD 8.59 billion in 2025, with a CAGR of 9.12%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com